GlassScriptPhysician profile
Tifany Nolan
NPI 1184880908
$10,732.43
in general payments reported to CMS, 2019-2025
32 companies · $731 in 2025
The $731 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,546 · 2021: $365 · 2022: $4,164 · 2023: $3,477 · 2024: $450 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,750 · Food and Beverage: $1,908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,750.00 |
| Food and Beverage | $1,907.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $5,665.64 | 2022-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $1,474.69 | 2019-2025 | Gardasil 9, Gardasil |
| Gynesonics, INC. | $554.26 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $346.60 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $340.18 | 2023-2025 | Veozah, Myrbetriq |
| Aspira Women'S Health INC | $240.81 | 2022 | |
| Hologic Sales and Service, LLC | $231.33 | 2021-2024 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Abbvie INC. | $187.05 | 2019-2024 | |
| Gen-Probe Sales & Service, INC. | $164.49 | 2022 | |
| Channel Medsystems, INC. | $152.66 | 2022-2023 | |
| Sage Therapeutics, LLC | $146.01 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $144.69 | 2019-2022 | |
| Ge Healthcare | $139.91 | 2023 | |
| Coopersurgical, INC. | $139.83 | 2021-2025 | Endosee, Paragard T 380a |
| Mayne Pharma Commercial LLC | $118.53 | 2022-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $99.36 | 2021-2025 | Slynd |
| Novo Nordisk INC | $77.08 | 2024-2025 | Wegovy |
| Currax Pharmaceuticals LLC | $73.08 | 2022-2024 | Contrave |
| Shield Therapeutics INC | $59.21 | 2023 | Accrufer |
| Millicent US INC | $46.01 | 2025 | Intrarosa, Femlyv |
| Exact Sciences Corporation | $41.71 | 2023-2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $36.11 | 2025 | |
| Ethicon US, LLC | $36.06 | 2022-2024 | Ethicon, Stratafix, Dermabond Prineo |
| Evofem Biosciences, INC. | $35.22 | 2021 | |
| Lilly USA, LLC | $27.94 | 2025 | Zepbound |
| Pfizer INC. | $26.45 | 2023 | |
| Daiichi Sankyo INC. | $24.55 | 2019 | |
| Scynexis, INC. | $22.57 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.05 | 2025 | Ultomiris |
| Urovant Sciences INC | $21.40 | 2022 | |
| Baxter Healthcare | $20.23 | 2025 | Perclot |
| Lupin INC. | $16.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tifany Nolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.